ABERA — Abera Bioscience AB Cashflow Statement
0.000.00%
- SEK74.92m
- SEK68.27m
Annual cashflow statement for Abera Bioscience AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | SAS | SAS | SAS | SAS | SAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -2.47 | -3.64 | -9.16 | -19.4 | -16.8 |
Changes in Working Capital | -0.519 | 0.893 | -0.516 | -0.299 | -0.91 |
Change in Accounts Receivable | |||||
Change in Other Liabilities | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -2.99 | -2.75 | -9.68 | -19.7 | -17.7 |
Other Investing Cash Flow Items | — | — | — | — | -0.025 |
Acquisition of Business | |||||
Cash from Investing Activities | — | — | — | — | -0.025 |
Financing Cash Flow Items | — | — | -2.37 | -0.892 | -0.009 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 5.14 | 1 | 20.7 | 23.2 | 5.6 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 2.15 | -1.75 | 11 | 3.48 | -12.1 |